The licensing of DCs to process and present tumor antigens requires interaction of DAMPs (e.g., HMGB1, HSP70) released from dying tumor cells, with Toll-like receptor 4 (TLR4) on DCs [102]. Here, TLR4 is linked to neoplasm.